Financial statements Tab-Pharm
Balance sheet of Tab-Pharm
Company age:
Age:
8 y. 7 m. 18 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of TAB-PHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 489 434,63 | 571 992,52 |
| A. Fixed assets | 16 575,00 | 28 783,34 |
| B. Current assets | 472 859,63 | 543 209,18 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 489 434,63 | 571 992,52 |
| A. Equity | -511 204,35 | -536 034,70 |
| B. Liabilities and provisions for liabilities | 1 000 638,98 | 1 108 027,22 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 1 000 638,98 | 1 108 027,22 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.